CSIMarket
 
Gsk Plc  (NYSE: GSK)
 

Gsk Plc's Customers Performance

GSK



 
GSK's Source of Revenues Gsk Plc's Corporate Customers have recorded an advance in their cost of revenue by 7.38 % in the 4 quarter 2025 year on year, sequentially costs of revenue grew by 3.3 %. During the corresponding time, Gsk Plc recorded a revenue increase by 37.35 % year on year, While revenue at the Gsk Plc's corporate clients recorded rose by 11.25 % year on year, sequentially revenue grew by 3.15 %.

List of GSK Customers




Gsk Plc's Customers have recorded an advance in their cost of revenue by 7.38 % in the 4 quarter 2025 year on year, sequentially costs of revenue grew by 3.3 %, for the same period Gsk Plc recorded revenue increase by 37.35 % year on year,

List of GSK Customers

Gsk Plc's Business Units
US    51.61 % of total Revenue
Wholesalers 1 US    16.36 % of total Revenue
Wholesalers 2 US    14.7 % of total Revenue
Wholesalers 3 US    9.81 % of total Revenue
Commercial Operations    100 % of total Revenue
Commercial Operations Specialty Medicines    41.25 % of total Revenue
Commercial Operations HIV oncology immuno-inflammation respiratory and other    41.25 % of total Revenue
Commercial Operations HIV    23.53 % of total Revenue
Commercial Operations Respiratory Immunology Inflammation    11.66 % of total Revenue
Commercial Operations Oncology    6.05 % of total Revenue
Commercial Operations Vaccines    28.03 % of total Revenue
Commercial Operations Shingles Meningitis RSV Influenza and Established Vaccines    28.03 % of total Revenue
Commercial Operations Shingles    10.89 % of total Revenue
Commercial Operations Meningitis    4.85 % of total Revenue
Commercial Operations RSV Arexvy    1.82 % of total Revenue
Commercial Operations Influenza    0.93 % of total Revenue
Commercial Operations Established Vaccines    9.55 % of total Revenue
Commercial Operations General Medicines    30.72 % of total Revenue
Commercial Operations Respiratory    21.64 % of total Revenue
Commercial Operations Other General Medicines    9.09 % of total Revenue
UK    2.09 % of total Revenue
Europe    20.97 % of total Revenue
International    25.33 % of total Revenue




   
Customers Net Income fell in Q4 by Customers Net margin fell to %
-46.9 % 1.63 %
Customers Net Income fell in Q4 by -46.9 %


Customers Net margin fell to 1.63 % 1.63 %



Gsk Plc's Customers, Q4 2025 Revenue Growth By Industry
Customers in Accident & Health Insurance Industry      11.84 %
Customers in Life Insurance Industry      27.58 %
Customers in Property & Casualty Insurance Industry      27.75 %
Customers in Investment Services Industry      67.78 %
Customers in Miscellaneous Financial Services Industry      4.68 %
Customers in Healthcare Facilities Industry      9.11 %
Customers in Pharmacy Services & Retail Drugstore Industry      8.17 %
Customers in Grocery Stores Industry      0.67 %
     
• Customers Valuation • Customers Mgmt. Effect.


Gsk Plc's Comment on Sales, Marketing and Customers
















GSK's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Gsk Plc 99,055.02 32,667.00 6,289.00 254
Aflac Incorporated 57,873.51 17,164.00 3,646.00 12,716
Cno Financial Group Inc 5,225.21 4,512.90 245.50 3,300
Futu Holdings Ltd 128,362.41 2,935.37 1,452.07 202
Molina Healthcare Inc 10,274.36 45,075.00 188.00 19,000
Trupanion Inc 1,095.53 1,481.38 25.80 1,121
SUBTOTAL 2,268,584.04 4,491,773.85 65,584.44 4,327,508
19 more clients available

Sign in to see all corporate customers for Gsk Plc.

Sources: Gsk Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Gsk Plc’s corporate clients.
For your research, we’ve provided 9 tables on Gsk Plc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.